Intrinsic Value of S&P & Nasdaq Contact Us

Aktis Oncology, Inc. AKTS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.00
+73.8%

Aktis Oncology, Inc. (AKTS) has 12 identified peers for comparison in the Healthcare sector. Peers include ADTN, AUDC, AVNW, CASA, CIEN, CMBM and others.

AKTS has a market capitalization of $952.71M, compared to an average peer market cap of $11.12B. AKTS is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message